CYCCCyclacel Pharmaceuticals, Inc.

Nasdaq cyclacel.com


$ 2.12 $ 0.04 (1.93 %)    

Tuesday, 07-May-2024 15:58:25 EDT
QQQ $ 440.32 $ 0.07 (0.02 %)
DIA $ 388.70 $ 0.29 (0.07 %)
SPY $ 517.26 $ 0.57 (0.11 %)
TLT $ 90.79 $ 0.55 (0.61 %)
GLD $ 214.23 $ -0.99 (-0.46 %)
$ 2.11
$ 2.08
$ 0.00 x 0
$ 0.00 x 0
$ 2.08 - $ 2.13
$ 1.30 - $ 13.20
248,038
na
2.78M
$ 1.34
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-21-2024 12-31-2023 10-K
2 11-29-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-08-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-30-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 05-12-2020 03-31-2020 10-Q
17 03-05-2020 12-31-2019 10-K
18 11-13-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 03-28-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-14-2018 03-31-2018 10-Q
25 03-30-2018 12-31-2017 10-K
26 11-13-2017 09-30-2017 10-Q
27 08-10-2017 06-30-2017 10-Q
28 05-12-2017 03-31-2017 10-Q
29 03-31-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-11-2016 06-30-2016 10-Q
32 05-13-2016 03-31-2016 10-Q
33 03-29-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
35 08-12-2015 06-30-2015 10-Q
36 05-12-2015 03-31-2015 10-Q
37 03-31-2015 12-31-2014 10-K
38 11-12-2014 09-30-2014 10-Q
39 08-12-2014 06-30-2014 10-Q
40 05-13-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 roth-mkm-maintains-buy-on-cyclacel-pharmaceuticals-lowers-price-target-to-11

Roth MKM analyst Jonathan Aschoff maintains Cyclacel Pharmaceuticals (NASDAQ:CYCC) with a Buy and lowers the price target fr...

Core News & Articles
Market-Moving News for April 30th
04/30/2024 12:45:17

MMM: 8.3% | 3M shares are trading higher following a Q1 earnings beat, reversing after initially falling. CYCC: 103% | Cyclace...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION